title: Ziprasidone and weight gain.
abstract: We describe the case of a 12-year-old white male in whom significant weight gain occurred within 3 months of treatment with Ziprasidone. It is important that clinicians are aware of this possibility since this medication is marketed as one of the few antipsychotic medications not associated with significant weight gain.
authors.affiliation: Shaare Zedek Medical Centre, Jerusalem, Israel. evesol@netvision.net.il
authors.forename: Sol
authors.initials: S
authors.lastname: Jaworowski
authors.forename: Shoshana
authors.initials: S
authors.lastname: Hauser
authors.forename: Joseph
authors.initials: J
authors.lastname: Mergui
authors.forename: Harry
authors.initials: H
authors.lastname: Hirsch
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D002648:Child; D006801:Humans; D008297:Male; D010879:Piperazines / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy*; D013844:Thiazoles / Q000009:adverse effects*; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone